Fact check
“During the Biden administration, HHS adopted an alternative test for "accepted medical use" that considers "widespread" clinical experience with a drug and requires "some credible scientific support" for at least one application.”
Reasoning
The evidence explicitly says that during the Biden administration, HHS embraced an alternative test for "accepted medical use" that considers "widespread" clinical experience and requires "some credible scientific support" for at least one application, matching the claim.
On confidence: The claim is directly supported by the provided excerpt from a Reason.com article citing a GAO report that states HHS adopted an alternative test during the Biden administration.
Important context
The alternative test is described as differing from the prior DEA criteria and aligns with the claim's description of the test's components.
Evidence
Supporting (2)
- Tier 1 — Primary sourceFederal drug scheduling relies on vague criteria, GAO report finds
similar to the evidence that the Food and Drug Administration (FDA) demands to approve a drug for prescription use, the DEA's definition essentially equated "accepted medical use" with FDA approval. During the Biden administration, the HHS…
- Tier 1 — Primary sourceFederal drug scheduling relies on vague criteria, GAO report finds
cannabis illustrates that puzzle. When Congress enacted the CSA in 1970, it placed marijuana in Schedule I, and the Drug Enforcement Administration (DEA), which had the authority to reclassify drugs in consultation with the Department of…
Limitations
The verification relies solely on the provided excerpt; no additional sources are consulted to confirm the broader context or official policy documents. No independent origin corroborated this claim, so it cannot be verified and confidence cannot be high.
- Last verified:
- Oct 2, 2026, 4:28 AM CDT
- Pipeline:
- 2.1.0
- Claim type:
- Factual
Where this claim appeared
Hazy Drug Classification Criteria Invite Dubious Bureaucratic JudgmentsReason · Jacob Sullum